Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by MacroGenics, Inc. on June 5, 2014. The record date for voting was April 16, 2014, with 27,619,894 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting results.
Material Changes and Voting Results
The document details the tabulation of votes for two proposals:
- Proposal 1 (Election of Directors): Two directors were elected to serve until the 2017 annual meeting.
- Scott Koenig, M.D., Ph.D.: 19,030,453 votes for, 332,028 votes withheld, 2,374,584 broker non-votes.
- Matthew Fust: 19,013,004 votes for, 349,477 votes withheld, 2,374,584 broker non-votes.
- Proposal 2 (Ratification of Auditors): The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2014, was ratified.
- Votes For: 21,631,256
- Votes Against: 77,169
- Abstentions: 28,640
- Broker Non-Votes: None recorded.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirmation that the two nominated directors (Scott Koenig and Matthew Fust) were successfully elected.
- Verification that Ernst & Young LLP is the appointed auditor for the fiscal year ending December 31, 2014.
- Review of the significant number of broker non-votes (2,374,584) on the director election proposal relative to the total shares outstanding.